Intriguingly, CENPM was significantly positively correlated with CTLA4, PDCD1, TIGIT and LAG3 (Fig. 7B), molecules that have been shown to be key immunotherapeutic targets in ccRCC [3]. The gene discussed is CENPM; the disease is nonpapillary renal cell carcinoma.